Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.

被引：0
|
作者：
Saito, Ryota
Inoue, Akira
Sugawara, Shunichi
Oizumi, Satoshi
Maemondo, Makoto
Okudera, Koichi
Suzuki, Toshiro
Usui, Kazuhiro
Harada, Masao
Morikawa, Naoto
Hasegawa, YUkihiro
Ishimoto, Osamu
Sakakibara, Tomohiro
Asahina, Hajime
Nukiwa, Toshihiro
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[3] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
[4] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan
[5] Hirosaki Chuo Hosp, Hirosaki, Aomori, Japan
[6] Iwate Isawa Hosp, Oushu, Japan
[7] Kanto Med Ctr NTT EC, Tokyo, Japan
[8] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[9] Tohoku Kosei Nenkin Hosp, Sendai, Miyagi, Japan
[10] Aomori Prefectural Cent Hosp, Aomori, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7086
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR REFRACTORY RELAPSED SMALL CELL LUNG CANCER (SCLC): NORTH JAPAN LUNG CANCER GROUP 0802
    Oizumi, S.
    Inoue, A.
    Sakakibara, T.
    Asahina, H.
    Sugawara, S.
    Maemondo, M.
    Okudera, K.
    Suzuki, T.
    Usui, K.
    Harada, M.
    Morikawa, N.
    Hasegawa, Y.
    Ishimoto, O.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 105 - 105
  • [2] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR ELDERLY PATIENTS WITH SMALL CELL LUNG CANCER (SCLC). (NORTH JAPAN LUNG CANCER GROUP 0405)
    Nakamura, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    Inoue, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 118
  • [3] Phase II study of amrubicin combined with carboplatin for refractory relapsed small-celllung cancer: North Japan Lung Cancer GroupTrial 0802
    Kawashima, Yosuke
    Inoue, Akira
    Sugawara, Shunichi
    Oizumi, Satoshi
    Maemondo, Makoto
    Okudera, Koichi
    Suzuki, Toshiro
    Usui, Kazuhiro
    Harada, Masao
    Morikawa, Naoto
    Hasegawa, Yukihiro
    Saito, Ryota
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Asahina, Hajime
    Nukiwa, Toshihiro
    RESPIRATORY INVESTIGATION, 2014, 52 (03) : 190 - 194
  • [4] Final result of phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for elderly patients with small cell lung cancer (SCLC)
    Ishimoto, O.
    Inoue, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
    Hirose, T.
    Shirai, T.
    Kusumoto, S.
    Sugiyama, T.
    Yamaoka, T.
    Okuda, K.
    Ohmori, T.
    Ohnishi, T.
    Adachi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] PHASE II STUDY OF AMRUBICIN (AMR) AND CARBOPLATIN (CBDCA) FOR INVASIVE THYMOMA (IT) AND THYMIC CARCINOMA (TC) : NORTH JAPAN LUNG CANCER GROUP 0803
    Kuyama, Shoichi
    Inoue, Akira
    Nakanishi, Masamoto
    Kawashima, Yosuke
    Harada, Masao
    Kobayashi, Kunihiko
    Kozuki, Toshiyuki
    Sakakibara, Tomohiro
    Maemondo, Makoto
    Asahina, Hajime
    Hisamoto, Akiko
    Nakagawa, Taku
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S647 - S647
  • [7] A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405
    Inoue, A.
    Ishimoto, O.
    Fukumoto, S.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Kanbe, M.
    Ogura, S.
    Harada, T.
    Oizumi, S.
    Harada, M.
    Sugawara, S.
    Fukuhara, T.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 800 - 803
  • [8] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
  • [9] A phase I study of amrubicin (AMR) and irinotecan (CPT-11) in relapsed small cell lung cancer(SCLC)
    Kawahara, M.
    Kubo, A.
    Komuta, K.
    Fukushima, M.
    Daimon, T.
    Furuse, K.
    Mio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
    Hirose, Takashi
    Nakashima, Masanao
    Shirai, Takao
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    LUNG CANCER, 2011, 73 (03) : 345 - 350
12345